Procept Biorobotics Corp

Common Name

Procept Biorobotics

Country

United States

Sector

Healthcare

Industry

Medical Devices

Employees

756

Ticker

PRCT

Exchange

NASDAQ/NMS

Website

www.procept-biorobotics.com

Description

Procept BioRobotics Corporation focuses on developing and commercializing surgical robotics technology. The company's flagship product, AquaBeam Robotic System, is designed to treat lower urinary trac... Show more

Income Statement Balance Sheet Group Entities

Procept Biorobotics's Financial Statements Preview

Below are the financial statements of Procept Biorobotics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of USD	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Current assets	—	—
Cash and cash equivalents	333.73^a	257.22^a
Accounts receivable, net	83.5^a	48.38^a
Inventory	56.17^a	39.76^a
Prepaid expenses and other current assets	8.45^a	5.21^a
Total current assets	481.84^a	350.57^a
Restricted cash, non-current	3.04^a	3.04^a
Property and equipment, net	26.71^a	28.75^a
Operating lease right-of-use assets, net	18.94^a	20.24^a
Intangible assets, net	0.93^a	1.2^a
Other assets	2.56^a	0.92^a
Total assets	534.02^a	404.72^a
Current liabilities	—	—
Accounts payable	10.03^a	13.5^a
Accrued compensation	21.54^a	16.89^a
Deferred revenue	9.57^a	5.66^a
Operating leases, current	1.91^a	1.68^a
Loan facility derivative liability	2^a	1.89^a
Other current liabilities	8.09^a	6.32^a
Total current liabilities	53.13^a	45.93^a
Long-term debt	51.47^a	51.34^a
Operating leases, non-current	26.87^a	26.18^a
Other non-current liabilities	0.32^a	0.52^a
Total liabilities	131.8^a	123.97^a
Stockholders’ equity	—	—
Preferred stock	0^a	0^a
Common stock	0^a	0^a
Additional paid-in capital	948.09^a	735.24^a
Accumulated other comprehensive gain	0.11^a	0.08^a
Accumulated deficit	-545.99^a	-454.57^a
Total stockholders’ equity	402.22^a	280.75^a
Total liabilities and stockholders’ equity	534.02^a	404.72^a

Download Data

Verified Sources Behind Procept Biorobotics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Procept Biorobotics’s data sources below and access millions more through our Disclosure Search.

a. Procept Biorobotics's 10-K 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Procept Biorobotics Corp

Procept Biorobotics's Financial Statements Preview

Verified Sources Behind Procept Biorobotics’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Dexcom Inc

Globus Medical Inc

Zimmer Biomet Holdings Inc

Stryker Corp

Masimo Corp

Penumbra Inc